Table 3.

Distribution of incidences of cancers and corresponding vitamin D status according to study population

OverallMonica10Inter99Health2006
Cancer typen(%)Mean (SD) 25-OH-D, nmol/Ln(%)Mean (SD) 25-OH-D, nmol/Ln(%)Mean (SD) 25-OH-D, nmol/Ln(%)Mean (SD) 25-OH-D, nmol/L
No incident cancer10,485(89.4)51.8 (26.5)1,952(77.5)64.4 (27.3)5,437(90.8)51.6 (26.5)3,096(96.0)44.1 (22.5)
All cancers1,248(10.6)57.4 (27.0)566(22.5)65.0 (26.0)552(9.2)51.6 (27.1)130(4.0)49.1 (22.9)
All cancers excl. NMSC951(8.0)56.6 (26.8)465(18.1)63.2 (25.6)388(6.4)50.7 (27.0)98(3.0)48.2 (24.1)
Head and neck cancer44(0.4)47.6 (33.0)17(0.6)72.1 (37.7)24(0.4)30.6 (17.0)3(0.1)44.0 (13.6)
Colorectal cancer153(1.2)54.0 (22.6)82(3.1)58.2 (19.5)58(0.9)48.3 (25.2)13(0.4)53.3 (24.9)
Cancer, bronchus and lung126(1.0)56.4 (24.9)84(3.2)59.5 (22.5)36(0.6)52.4 (29.5)6(0.2)36.5 (16.5)
Cancer of the breast174(1.4)56.0 (26.8)64(2.4)63.4 (25.7)81(1.3)53.9 (28.7)29(0.9)45.9 (19.2)
Cancer of the uterus27(0.2)61.7 (26.9)11(0.4)75.2 (27.7)16(0.3)52.5 (22.8)0 (0)NA
Prostate cancer133(1.1)60.5 (28.6)64(2.4)68.4 (24.6)52(0.9)52.4 (27.3)17(0.5)55.2 (38.7)
Cancer, urinary organs48(0.4)61.3 (25.3)30(1.1)65.1 (26.6)12(0.2)57.3 (26.6)6(0.2)49.8 (10.5)
Malignant melanoma56(0.5)59.4 (27.9)18(0.7)70.1 (24.1)30(0.5)58.5 (29.6)8(0.2)39.2 (17.8)
NMSC398(3.3)60.4 (27.0)157(6.1)71.1 (25.5)196(3.2)53.6 (26.9)45(1.4)52.6 (20.6)

NOTE: Since some persons develop more than one cancer, the percentages do not add up.

Abbreviation: NA, not applicable.